Finalgon cream d / nar. approx. tube 35g
Release form:
Cream
Ointment
Category
Bruises, sprains
Scope of the drug
Musculoskeletal system
Release form
Cream
Manufacturer country
Germany
Package quantity, pcs
one
Manufacturer
Boehringer Ingelheim, Austria
Structure
Nonivamide - 1.7 mg, nicoboxil - 10.8 mg.
Excipients: decyl oleate - 50 mg, emulsifier F - 10 mg, macrogol cetostearyl ether - 30 mg, stearic acid - 2 mg, cetostearyl alcohol - 20 mg, liquid paraffin - 30 mg, sorbic acid - 2 mg, vegetable perfume oil - 2 mg, purified water - 823.5 mg.
pharmachologic effect
Pharmacodynamics
Nonivamide is a synthetic analogue of capsaicin and has analgesic properties, which are manifested as a result of the gradual penetration of the active substance into the peripheral nociceptive C-fibers and A-delta nerve fibers upon repeated application of the drug to the skin.
Nonivamide has a vasodilating effect, which is accompanied by an intense, prolonged sensation of warmth, due to the stimulation of afferent nerve endings in the skin.
Nicoboxil is a derivative of nicotinic acid with vasodilating properties with the participation of prostaglandins I2 and E2.
The hyperemic effect of nicoboxil (butoxyethyl ester of nicotinic acid) develops faster and has a greater intensity than the hyperemic effect of nonivamide.
Combined action
Nonivamide and nicoboxil have complementary vasodilating properties, cause flushing of the skin, increase the rate of enzymatic reactions, and activate metabolism.
The appearance of hyperemia and an increase in skin temperature within a few minutes after application indicate the rapid penetration of the active components of the drug into the skin.
Finalgon's action manifests itself locally, develops after a few minutes and reaches a maximum after 20-30 minutes.
Pharmacokinetics
Data on the pharmacokinetics of Finalgon® are not available.
Indications
Arthritis
arthralgia and myalgia of rheumatic genesis
sports injuries, bruises and damage to the ligamentous apparatus
myalgia caused by excessive physical exertion
lumbago
neuritis
ishalgia
bursitis and tendovaginitis
for preliminary warming up" of muscles before physical exercises, sports competitions
as part of complex vasodilator therapy for peripheral circulatory disorders.
Contraindications
Hypersensitivity to nicoboxil, nonivamide or excipients of the drug
children under 12 years old.
the drug should not be applied to sensitive skin, open wounds, inflamed skin areas, skin areas with increased permeability: neck, lower abdomen, inner thighs.
Side effects
In the course of long-term experience with the drug, the following side effects were identified:
From the immune system: anaphylactic reactions, hypersensitivity.
From the nervous system: paresthesia, burning sensation of the skin.
From the respiratory system: cough, shortness of breath.
On the part of the skin and subcutaneous tissues: vesicles or pustules at the site of application, local skin reaction (for example, contact dermatitis), itching, rash, facial swelling, urticaria, a feeling of heat at the site of application.
Interaction
Drug interaction of Finalgon® with other drugs used locally or systemically has not been identified.
How to take, course of administration and dosage
Treatment should be started by applying a small amount of the drug to a small area of the skin to assess the individual response.
The individual reaction to the drug can differ significantly: for some people, it will be enough to apply a small amount of ointment in order to cause the necessary warming effect.
Using the supplied applicator, a column of preparation no more than 0.5 cm in size is applied to the appropriate area of the skin the size of a palm with light rubbing movements.
To enhance the therapeutic effect, the area of the skin to which the drug is applied can be covered with a woolen cloth.
P
Name ENG
FINALGON
Clinical and pharmacological group
A preparation with a local irritant and analgesic effect
ATX code
Other drugs
Dosage
10.8mg / g + 1.7mg / g x 35g
Structure
nonivamide - 1.7 mg, nicoboxil - 10.8 mg.
Excipients: decyl oleate - 50 mg, emulsifier F - 10 mg, macrogol cetostearyl ether - 30 mg, stearic acid - 2 mg, cetostearyl alcohol - 20 mg, liquid paraffin - 30 mg, sorbic acid - 2 mg, vegetable perfume oil - 2 mg, purified water - 823.5 mg.
Indications
Arthritis
arthralgia and myalgia of rheumatic genesis
sports injuries, bruises and damage to the ligamentous apparatus
myalgia caused by excessive physical exertion
lumbago
neuritis
ishalgia
bursitis and tendovaginitis
for preliminary "warming up" of muscles before physical exercises, sports competitions
as part of complex vasodilator therapy for peripheral circulatory disorders.
INN / Active ingredient
Nonivamide + nicoboxil
Contraindications
Hypersensitivity to nicoboxil, nonivamide or excipients of the drug
children under 12 years of age.
the drug should not be applied to sensitive skin, open wounds, inflamed skin areas, areas of skin with increased permeability: neck, lower abdomen, inner thighs.
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 3 years
Specifications
Category
Bruises, sprains
Scope of the drug
Musculoskeletal system
Release form
Cream
Manufacturer country
Germany
Package quantity, pcs
one
Minimum age from
12 years
Way of introduction
Outwardly
Vacation conditions
Without recipe
Brand name
Sanofi
The amount of the dosage form in the primary package
35 g
Primary packaging type
Tuba
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Local irritant
Anatomical and therapeutic characteristics
M02AX10 Other preparations
Dosage form
Cream for external use
Item weight, g
35
Expiration date in days
1095
The target audience
Children
Dosage (volume) of the substance in the preparation
nicoboxil - 10.8 mg, nonivamide - 1.7 mg
Package weight, g
fifty
Mode of application
:
Treatment should be started by applying a small amount of the drug to a small area of the skin to assess the individual response. The individual reaction to the drug can vary significantly: for some people it will be enough to apply a small amount of ointment in order to cause the necessary warming effect. < br> With the help of the attached applicator, a column of preparation no more than 0.5 cm in size is applied to the appropriate area of the skin the size of a palm with light rubbing movements. To enhance the therapeutic effect, the area of the skin to which the drug is applied can be covered with a woolen cloth. < br> With repeated use, the reaction to the ointment may decrease, which requires an increase in the dose, which is selected individually. < br> If necessary, the cream is used 2-3 times / day. < br> For preliminary warming up of muscles before physical exercises, sports competitions it is recommended to rub in about 30 minutes before their start. < br> The patient should be warned that in the absence of the desired effect within 10 days, you should consult a doctor. < br> After applying the drug to the skin, wash your hands thoroughly with soap and water.
Drug action
:
Pain reliever
,
Warming up
,
Analgesic
,
Vasodilator
Information on technical characteristics, delivery set, country of manufacture "